Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Zhonglun (Shanghai) Law Firm on the 2023 Annual General Meeting of Shareholders of Jiangxi Tianxin Pharmaceutical Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Announcement on additional provisional proposals for the 2023 Annual General Meeting of Shareholders
Notice on changing the scope of business of the company, amending the company's articles of association, and registration of industrial and commercial changes
Notice on convening the 2023 Annual General Meeting of Shareholders
2023 Internal Control Evaluation Report
2023 Board Audit Committee Performance Report
Report on the performance of supervisory duties of accounting firms by the Audit Committee of the Board of Directors in 2023
Special report of the board of directors on the 2023 independent directors' independence self-inspection
Accounting Services Selection and Hiring System
Board of Directors Rules of Procedure
Announcement on the use of idle own funds for fund management
Notice on changing the company's registered address, legal representative, amending the company's articles of association, and registration of industrial and commercial changes
Notice on the change of signatory accountant
Announcement on the shareholding situation of the top ten shareholders and the top ten shareholders with unlimited sale conditions for share repurchases
Jiangxi Tianxin Pharmaceutical Co., Ltd. Independent Directors\' Special Meeting Working System
Notice on receiving a warning letter from the Jiangxi Regulatory Bureau
Announcement on the signing of a four-party supervision agreement for special account storage of funds raised
No Data